Stay updated on Immunotherapy for Bladder Cancer Patients Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy for Bladder Cancer Patients Clinical Trial page.
Latest updates to the Immunotherapy for Bladder Cancer Patients Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check14 days agoChange DetectedThe website has updated the contact details section for the study, now specifying that it provides information for questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference2%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedSeveral key resources related to genetics and cancer treatment have been removed, including links to MedlinePlus and DailyMed, which may impact access to important medical information.SummaryDifference4%
- Check36 days agoChange DetectedNew resources related to bladder cancer and immunotherapy drugs Ipilimumab and Nivolumab have been added, along with links to major health organizations and databases.SummaryDifference0.5%
- Check43 days agoChange DetectedThe website has been updated to version v2.12.2, adding new features for downloading data in various formats and providing detailed participant and study information, while removing the previous version v2.12.1.SummaryDifference4%
- Check51 days agoChange DetectedNew contact information for Gopakumar Iyer, MD has been added, while the details for Min Yuen Teo, MD have been removed, indicating a personnel update.SummaryDifference3%
Stay in the know with updates to Immunotherapy for Bladder Cancer Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy for Bladder Cancer Patients Clinical Trial page.